Literature DB >> 1993557

Differential influence of organ site on three subpopulations of a single mouse mammary tumor at two distinct steps in metastasis.

C J Aslakson1, J W Rak, B E Miller, F R Miller.   

Abstract

Tumor subpopulations 66c14, 168FARN, and 4T07 are drug-resistant variants selected from sister subpopulations derived from a single mouse mammary tumor. These subpopulations are heterogeneous in their capacities to form experimental metastatic growth in the lungs and liver. Initial survival kinetics of arrested cells, determined by the clearance of 125IUdR-labelled cells, and subsequent growth rates, determined by sequential recovery of clonogenic tumor cells from occult metastases, both correlated with organ-colonizing potential as determined by necropsy. The growth rates of these 3 subpopulations were determined in vitro in monolayer and in situ in the subcutis, in the liver following intrasplenic injection, and in the lung following intravenous injection. Clonogenic potential of all 3 lines was similar in vitro (54-59%). Growth rates in vitro (population doubling times 16.5-21 hr) and in the subcutis (tumor volume doubling times 5.2-7.4 days) were similar for the 3 subpopulations, but differed significantly in the liver and lungs. For line 4T07, the most metastatic line to both lung and liver, population doubling times in vitro and in the lung and liver were similar, ranging from 17 to 26 hr. For lines 66c14 and 168FARN, the growth rates in lungs and livers were much slower than in vitro. Line 66c14, which is relatively more metastatic to the lungs, grew much faster in the lung (39 hours) than in the liver (91 hr), but line 168FARN, which is relatively more metastatic to the liver, grew at a faster rate in the liver (37 hr) than in the lung (63 hr). Thus, 3 tumor subpopulations (seeds) derived from a single tumor were differentially affected by host organ factors (soil) at 2 distinct stages in the metastatic process.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1993557     DOI: 10.1002/ijc.2910470327

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

1.  Comparative effects of thermosensitive doxorubicin-containing liposomes and hyperthermia in human and murine tumours.

Authors:  Pavel S Yarmolenko; Yulin Zhao; Chelsea Landon; Ivan Spasojevic; Fan Yuan; David Needham; Benjamin L Viglianti; Mark W Dewhirst
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

Review 2.  Mechanisms of disseminated cancer cell dormancy: an awakening field.

Authors:  María Soledad Sosa; Paloma Bragado; Julio A Aguirre-Ghiso
Journal:  Nat Rev Cancer       Date:  2014-08-14       Impact factor: 60.716

3.  Use of tumor lines with selectable markers in assessing the effect on experimental metastases of combination chemotherapy with alkylating agents.

Authors:  B E Miller; L Delmonico; K Vistisen; F R Miller
Journal:  Clin Exp Metastasis       Date:  1998-07       Impact factor: 5.150

4.  Cyclooxygenase-2-dependent lymphangiogenesis promotes nodal metastasis of postpartum breast cancer.

Authors:  Traci R Lyons; Virginia F Borges; Courtney B Betts; Qiuchen Guo; Puja Kapoor; Holly A Martinson; Sonali Jindal; Pepper Schedin
Journal:  J Clin Invest       Date:  2014-08-18       Impact factor: 14.808

Review 5.  Cancer progression and the invisible phase of metastatic colonization.

Authors:  Christoph A Klein
Journal:  Nat Rev Cancer       Date:  2020-10-06       Impact factor: 60.716

6.  Contribution of host-derived tissue factor to tumor neovascularization.

Authors:  Joanne Yu; Linda May; Chloe Milsom; G Mark Anderson; Jeffrey I Weitz; James P Luyendyk; George Broze; Nigel Mackman; Janusz Rak
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-09-04       Impact factor: 8.311

7.  KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer.

Authors:  Kiranmai Gumireddy; Anping Li; Phyllis A Gimotty; Andres J Klein-Szanto; Louise C Showe; Dionyssios Katsaros; George Coukos; Lin Zhang; Qihong Huang
Journal:  Nat Cell Biol       Date:  2009-10-04       Impact factor: 28.824

Review 8.  Breast cancer dormancy: need for clinically relevant models to address current gaps in knowledge.

Authors:  Grace G Bushnell; Abhijeet P Deshmukh; Petra den Hollander; Ming Luo; Rama Soundararajan; Dongya Jia; Herbert Levine; Sendurai A Mani; Max S Wicha
Journal:  NPJ Breast Cancer       Date:  2021-05-28

9.  Complementation of two related tumour cell classes during experimental metastasis tagged with different histochemical marker genes.

Authors:  W C Lin; K L O'Connor; L A Culp
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

10.  Oncogenic RAS drives the CRAF-dependent extracellular vesicle uptake mechanism coupled with metastasis.

Authors:  Dongsic Choi; Laura Montermini; Brian Meehan; Anthoula Lazaris; Peter Metrakos; Janusz Rak
Journal:  J Extracell Vesicles       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.